Motilal Oswal Financial Services Ltd (MOFSL) is bullish on Westlife Development. The brokerage firm has initiated coverage on the stock with a ‘neutral’ rating and a target price of Rs 440. With a three-year perspective, Motilal Oswal sees a target price of Rs 800 on the stock.
Haitong Securities has initiated coverage on Gland Pharma with a ‘neutral’ rating and a target price of Rs 2,790. The brokerage house believes double-digit growth is possible for the pharma company.
CNBC-TV18’s Nimesh Shah has more details.
To watch other videos in this series, click on the Standout Brokerage Report tab below.
(Edited by : Niral Sharma)
First Published: Dec 23, 2020 10:12 AM IST